Bayer unpacks plans for $2.2B manufacturing site in Ohio
Bayer plans a $2.2B manufacturing campus in New Albany, OH, creating about 600 jobs, with drug substance production starting in 2031. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push for…
Bayer on Friday laid out its vision for a $2.2 billion manufacturing site in Ohio that would create about 600 new jobs in the area.
The drugmaker described the site in New Albany as a ...
Source: Endpoints News